{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T09:31:42Z","timestamp":1777541502295,"version":"3.51.4"},"reference-count":34,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2002,8,1]],"date-time":"2002-08-01T00:00:00Z","timestamp":1028160000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2002,8,1]],"date-time":"2002-08-01T00:00:00Z","timestamp":1028160000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2002,8]]},"DOI":"10.1124\/jpet.302.2.710","type":"journal-article","created":{"date-parts":[[2003,1,10]],"date-time":"2003-01-10T18:44:00Z","timestamp":1042224240000},"page":"710-716","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":76,"title":["Cocaine Metabolism Accelerated by a Re-Engineered Human Butyrylcholinesterase"],"prefix":"10.1016","volume":"302","author":[{"given":"Hong","family":"Sun","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maryann L.","family":"Shen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuan-Ping","family":"Pang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oksana","family":"Lockridge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen","family":"Brimijoin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1124\/jpet.302.2.710_bib1","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0009-2797(99)00013-7","article-title":"Association of tetramers of human butyrylcholinesterase is mediated by conserved aromatic residues of the carboxy terminus.","volume":"119\u2013120","author":"Altamirano","year":"1999","journal-title":"Chem-Biol Interact"},{"key":"10.1124\/jpet.302.2.710_bib2","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1021\/bi00453a015","article-title":"Structure of the gene for human butyrylcholinesterase. Evidence for a single copy.","volume":"29","author":"Arpagaus","year":"1990","journal-title":"Biochemistry"},{"key":"10.1124\/jpet.302.2.710_bib3","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1002\/(SICI)1099-1263(199807\/08)18:4<227::AID-JAT511>3.0.CO;2-6","article-title":"Kinetics and rat locomotor activity following cocaine and lidocaine administration.","volume":"18","author":"Barat","year":"1998","journal-title":"J Appl Toxicol"},{"key":"10.1124\/jpet.302.2.710_bib4","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1016\/0024-3205(92)90303-7","article-title":"The presence of cocaine and benzoylecgonine in rat cerebrospinal fluid after the intravenous administration of cocaine.","volume":"51","author":"Barbieri","year":"1992","journal-title":"Life Sci"},{"key":"10.1124\/jpet.302.2.710_bib5","series-title":"Drug Dosage in Laboratory Animals: A Handbook","first-page":"102","author":"Borchard","year":"1990"},{"key":"10.1124\/jpet.302.2.710_bib6","first-page":"367","article-title":"Butyrylcholinesterase accelerates cocaine metabolism: in vitro and in vivo effects in nonhuman primates and humans.","volume":"28","author":"Carmona","year":"2000","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/jpet.302.2.710_bib7","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1037\/1064-1297.6.3.274","article-title":"Attenuation of cocaine-induced locomotor activity by butyrylcholinesterase.","volume":"6","author":"Carmona","year":"1998","journal-title":"Exp Clin Psychopharmacol"},{"key":"10.1124\/jpet.302.2.710_bib8","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1093\/jat\/12.4.200","article-title":"Correlation of saliva cocaine levels with plasma levels and with pharmacologic effects after intravenous cocaine administration in human subjects.","volume":"12","author":"Cone","year":"1988","journal-title":"J Anal Toxicol"},{"key":"10.1124\/jpet.302.2.710_bib9","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0376-8716(97)00119-1","article-title":"Enhancing cocaine metabolism with butyrylcholinesterase as a treatment strategy.","volume":"48","author":"Gorelick","year":"1997","journal-title":"Drug Alcohol Depend"},{"key":"10.1124\/jpet.302.2.710_bib10","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/S0196-0644(05)80883-2","article-title":"Association between life-threatening cocaine toxicity and plasma cholinesterase activity.","volume":"21","author":"Hoffman","year":"1992","journal-title":"Ann Emerg Med"},{"key":"10.1124\/jpet.302.2.710_bib11","doi-asserted-by":"crossref","first-page":"259","DOI":"10.3109\/15563659609013786","article-title":"Administration of purified human plasma cholinesterase protects against cocaine toxicity in mice.","volume":"34","author":"Hoffman","year":"1996","journal-title":"J Toxicol Clin Toxicol"},{"key":"10.1124\/jpet.302.2.710_bib12","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1056\/NEJM199511093331907","article-title":"The management of cocaine-associated myocardial ischemia.","volume":"333","author":"Hollander","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1124\/jpet.302.2.710_bib13","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0021-9673(00)85339-X","article-title":"Determination of cocaine in human urine, plasma and red blood cells by gas-liquid chromatography.","volume":"152","author":"Javaid","year":"1978","journal-title":"J Chromatogr"},{"key":"10.1124\/jpet.302.2.710_bib14","doi-asserted-by":"crossref","first-page":"22840","DOI":"10.1074\/jbc.272.36.22840","article-title":"The mammalian gene of acetylcholinesterase-associated collagen.","volume":"272","author":"Krejci","year":"1997","journal-title":"J Biol Chem"},{"key":"10.1124\/jpet.302.2.710_bib15","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1126\/science.8456315","article-title":"Antibody-catalyzed degradation of cocaine.","volume":"259","author":"Landry","year":"1993","journal-title":"Science (Wash DC)"},{"key":"10.1124\/jpet.302.2.710_bib16","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1038\/nsb742","article-title":"Crystal structure of a bacterial cocaine esterase.","volume":"9","author":"Larsen","year":"2002","journal-title":"Nat Struct Biol"},{"key":"10.1124\/jpet.302.2.710_bib17","first-page":"444","article-title":"Acute effects of cocaine on spontaneous and discriminative motor functions: relation to route of administration and pharmacokinetics.","volume":"257","author":"Lau","year":"1991","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.302.2.710_bib18","first-page":"535","article-title":"Pharmacokinetic-pharmacodynamic modeling of the psychomotor stimulant effect of cocaine after intravenous administration: timing performance deficits.","volume":"288","author":"Lau","year":"1999","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.302.2.710_bib19","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1046\/j.1471-4159.2000.751320.x","article-title":"Abundant tissue butyrylcholinesterase and its possible function in the acetylcholinesterase knockout mouse.","volume":"75","author":"Li","year":"2000","journal-title":"J Neurochem"},{"key":"10.1124\/jpet.302.2.710_bib20","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1006\/taap.1997.8187","article-title":"Cocaine detoxification by human plasma butyrylcholinesterase.","volume":"145","author":"Lynch","year":"1997","journal-title":"J Appl Pharmacol"},{"key":"10.1124\/jpet.302.2.710_bib21","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1016\/0024-3205(90)90169-R","article-title":"Effects of cocaine and cocaine metabolites on cerebral arteries in vitro.","volume":"47","author":"Madden","year":"1990","journal-title":"Life Sci"},{"key":"10.1124\/jpet.302.2.710_bib22","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1006\/taap.1997.8188","article-title":"Therapeutic use of butyrylcholinesterase for cocaine intoxication.","volume":"145","author":"Mattes","year":"1997","journal-title":"Toxicol Appl Pharmacol"},{"key":"10.1124\/jpet.302.2.710_bib23","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/0376-8716(77)90004-7","article-title":"Disposition and metabolism of [3H] cocaine in acutely and chronically treated monkeys.","volume":"2","author":"Misra","year":"1977","journal-title":"Drug Alcohol Depend"},{"key":"10.1124\/jpet.302.2.710_bib24","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0378-4347(97)00393-9","article-title":"Sensitive and specific high-performance liquid chromatographic assay with ultraviolet detection for the determination of cocaine and its metabolites in rat plasma.","volume":"703","author":"Pan","year":"1997","journal-title":"J Chromatogr B Biomed Sci Appl"},{"key":"10.1124\/jpet.302.2.710_bib25","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1021\/js980283h","article-title":"Cocaine and alcohol interactions in the rat: contribution of cocaine metabolites to the pharmacological effects.","volume":"88","author":"Pan","year":"1999","journal-title":"J Pharm Sci"},{"key":"10.1124\/jpet.302.2.710_bib26","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1124\/mol.53.1.112","article-title":"Role of oligosaccharides in the pharmacokinetics of tissue-derived and genetically engineered cholinesterases.","volume":"53","author":"Saxena","year":"1998","journal-title":"Mol Pharmacol"},{"key":"10.1124\/jpet.302.2.710_bib27","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.1021\/ac981060e","article-title":"A validated stable isotope dilution liquid chromatography tandem mass spectrometry assay for the trace analysis of cocaine and its major metabolites in plasma.","volume":"71","author":"Singh","year":"1999","journal-title":"Anal Chem"},{"key":"10.1124\/jpet.302.2.710_bib28","first-page":"171","article-title":"N-Demethylation of cocaine in the rat and in isolated rat hepatocytes: comparison with aminopyrine demethylation.","volume":"207","author":"Stewart","year":"1978","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.302.2.710_bib29","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1016\/0024-3205(77)90448-9","article-title":"Hydrolysis of cocaine in human plasma by cholinesterase.","volume":"20","author":"Stewart","year":"1977","journal-title":"Life Sci"},{"key":"10.1124\/jpet.302.2.710_bib30","doi-asserted-by":"crossref","first-page":"9330","DOI":"10.1074\/jbc.M006676200","article-title":"Predicted Michaelis-Menten complexes of cocaine-butyrylcholinesterase: engineering effective butyrylcholinesterase mutants for cocaine detoxification.","volume":"276","author":"Sun","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1124\/jpet.302.2.710_bib31","doi-asserted-by":"crossref","unstructured":"Sun H, Pang YP, Lockridge O, and Brimijoin S (2002) Re-engineering butyrylcholinesterase as a cocaine hydrolase. Mol Pharmacol, in press.","DOI":"10.1124\/mol.62.2.220"},{"key":"10.1124\/jpet.302.2.710_bib32","first-page":"1183","article-title":"Simultaneous pharmacokinetic modeling of cocaine and its metabolites, norcocaine and benzoylecgonine, after intravenous and oral administration in rats.","volume":"29","author":"Sun","year":"2001","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/jpet.302.2.710_bib33","doi-asserted-by":"crossref","first-page":"2519","DOI":"10.1001\/jama.1979.03290490025018","article-title":"Death caused by recreational cocaine use.","volume":"241","author":"Wetli","year":"1979","journal-title":"J Am Med Assoc"},{"key":"10.1124\/jpet.302.2.710_bib34","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0026-895X(24)23159-X","article-title":"An improved cocaine hydrolase: the A328Y mutant of human butyrylcholinesterase is 4-fold more efficient.","volume":"55","author":"Xie","year":"1999","journal-title":"Mol Pharmacol"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524358197?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524358197?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/jpet.302.2.710","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,4]],"date-time":"2025-01-04T15:34:42Z","timestamp":1736004882000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022356524358197"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,8]]},"references-count":34,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2002,8]]}},"alternative-id":["S0022356524358197"],"URL":"https:\/\/doi.org\/10.1124\/jpet.302.2.710","relation":{},"ISSN":["0022-3565"],"issn-type":[{"value":"0022-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2002,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cocaine Metabolism Accelerated by a Re-Engineered Human Butyrylcholinesterase","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/jpet.302.2.710","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2002 American Society for Pharmacology and Experimental Therapeutics. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}